Why is Mangalam Drugs falling/rising?

As of 23-Sep, Mangalam Drugs and Organics Ltd is currently priced at 75.00, reflecting a decline of 0.58, or 0.77%. The stock has been underperforming, having lost 1.17% over the last two days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of returns, the stock has seen a significant decline of 35.32% year-to-date and 40.99% over the past year, while it has marginally outperformed the benchmark Sensex over the past week with a gain of 0.07% compared to the Sensex's drop of 0.34%. Positive factors such as a 30.02% increase in delivery volume on September 22 indicate rising investor participation, but there are no specific positive or negative factors available to further explain the stock's recent movement.
Broader Market Context: In the broader market, the Sensex has shown a positive return of 5.07% year-to-date and a decline of only 3.33% over the past year, contrasting sharply with Mangalam Drugs' significant losses. This disparity highlights the stock's underperformance relative to the benchmark, particularly over longer periods such as the last three and five years, where the stock has fallen by 50.96% and 45.38%, respectively, while the Sensex has gained considerably. The overall market conditions appear to be more favorable, which further emphasizes the challenges faced by Mangalam Drugs in maintaining its stock price.